Accueil   Diary - News   All news CALIXAR and VirPath develop an innovative manufacturing process

CALIXAR and VirPath develop an innovative manufacturing process

CALIXAR, a start-up providing services focused on membrane proteins, and VirPath, an academic lab specialized in the study of influenza viruses, announce a breakthrough in the manufacturing of high performance vaccines. Their current focus is on vaccines for influenza viruses.

 

 

Read the press release